All In Biotech

Free tool

FAERS Monitor: Treanda

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022303 or its brand name (Treanda, Bendamustine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

11,430

Serious

9,922

87% of reports

Hospitalization

4,450

Death reported

2,006

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use1,082
  • pyrexia842
  • disease progression569
  • febrile neutropenia522
  • rash516
  • neutropenia487
  • pneumonia458
  • drug ineffective438
  • platelet count decreased435
  • neutrophil count decreased418
  • product use in unapproved indication411
  • covid-19406
  • anaemia391
  • pancytopenia380
  • malignant neoplasm progression379

Reports by year received

View as table
YearReports
200856
2009180
2010293
2011278
20121,407
2013512
2014473
2015628
2016554
2017534
2018683
2019640
2020654
2021752
20221,463
20231,034
2024755
2025301
2026233

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,729 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
neutrophil count decreasedSignal41819.117.37,074
febrile neutropeniaSignal52214.613.46,562
pancytopeniaSignal38012.611.44,026
disease progressionSignal5698.98.23,978
platelet count decreasedSignal4357.56.92,462
malignant neoplasm progressionSignal3796.86.21,883
neutropeniaSignal4876.66.12,320
pyrexiaSignal8424.54.22,310
covid-19Signal4064.33.91,018
anaemiaSignal3913.83.4802
product use in unapproved indicationSignal4113.12.8572
pneumoniaSignal4582.62.4458
off label useSignal1,0822.32.1805
rashSignal5162.22.0335
drug ineffective4380.60.6115

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.